Home / Drug News / FDA expands indications for SculpSure

FDA expands indications for SculpSure

The U.S. Food and Drug Administration granted an expanded FDA 510(k) clearance in September for Cynosure’s non-invasive body contouring product, SculpSure. This body contouring laser treatment is now cleared to treat the submental area. SculpSure has also been cleared to treat the abdomen, flanks, back, and inner and outer thighs. This treatment uses a laser to raise the temperature of body fat to disrupt and destroy fat cells, which are then naturally and permanently eliminated.

About Dr. J. Kim

Dr Kim developed (and is continuing to develop) dermatology research news as we way from dermatologists to stay on top of the latest advances in the field of dermatology.

Check Also

atopic dermatitis serlopitant

Recruitment underway for atopic dermatitis serlopitant trial

An investigational treatment that inhibits a receptor implicated in itch may hold promise for treatment …

Leave a Reply

Your email address will not be published. Required fields are marked *